| Ticker Details |
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries Ltd is a pharmaceutical company which develops, produces and markets generic and specialty medicines which include chemical and therapeutic medicines in a variety of dosage forms and central nervous system medicines.
|
| IPO Date: |
March 26, 1990 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$39.67B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.39 | 1.32%
|
| Avg Daily Range (30 D): |
$0.43 | 1.28%
|
| Avg Daily Range (90 D): |
$0.46 | 1.43%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
7.71M |
| Avg Daily Volume (30 D): |
5.33M |
| Avg Daily Volume (90 D): |
6.48M |
| Trade Size |
| Avg Trade Size (Sh.): |
235 |
| Avg Trade Size (Sh.) (30 D): |
105 |
| Avg Trade Size (Sh.) (90 D): |
114 |
| Institutional Trades |
| Total Institutional Trades: |
81,268 |
| Avg Institutional Trade: |
$2.32M |
| Avg Institutional Trade (30 D): |
$4.97M |
| Avg Institutional Trade (90 D): |
$4.55M |
| Avg Institutional Trade Volume: |
.08M |
| Avg Institutional Trades (Per Day): |
14 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.77M |
| Avg Closing Trade (30 D): |
$17.1M |
| Avg Closing Trade (90 D): |
$18.06M |
| Avg Closing Volume: |
269.39K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$1.37
|
$.32
|
$.42
|
|
Diluted EPS
|
$1.33
|
$.31
|
$.41
|
|
Revenue
|
$14.14B
|
$3.98B
|
$1.5B
|
|
Gross Profit
|
$9.03B
|
$1.97B
|
$2.66B
|
|
Net Income / Loss
|
$1.57B
|
$369M
|
$481M
|
|
Operating Income / Loss
|
$2.29B
|
$652M
|
$300M
|
|
Cost of Revenue
|
$8.32B
|
$2.01B
|
$2.06B
|
|
Net Cash Flow
|
$2.04B
|
$185M
|
$1.35B
|
|
PE Ratio
|
|
|
|
| Splits |
|
Jul 01, 2004
|
2:1
|
|
Dec 06, 2002
|
2:1
|
|
Feb 23, 2000
|
2:1
|
|
|
|
